| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/31/2008 | WO2008091225A1 Comparative detection of structure patterns in interaction sites of molecules |
| 07/31/2008 | WO2008091168A1 A device for determining fiber content and the method of fiber content determination |
| 07/31/2008 | WO2008091031A1 Method of arraying cells at single-cell level inside microfluidic channel and method of analysing cells using the same, and cell analysis chip used for carrying out the same |
| 07/31/2008 | WO2008090941A1 Method of evaluating ibd, amino acid data processor, amino acid data processing method, amino acid data processing system, amino acid data processing program and recording medium |
| 07/31/2008 | WO2008090930A1 Method for diagnosis of cancer |
| 07/31/2008 | WO2008090922A1 Analysis chip and analysis method |
| 07/31/2008 | WO2008090760A1 Fluorescent detector, microchip and examination system |
| 07/31/2008 | WO2008090759A1 General microanalysis system |
| 07/31/2008 | WO2008090749A1 Agent for modification of sh group |
| 07/31/2008 | WO2008090742A1 Non-human animal for eye disease model |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090645A1 Analytical method and analytical apparatus |
| 07/31/2008 | WO2008090535A1 Remote detection of vapour with enhancement of evaporation by heating |
| 07/31/2008 | WO2008090360A1 Methods |
| 07/31/2008 | WO2008090332A2 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| 07/31/2008 | WO2008090319A2 Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| 07/31/2008 | WO2008090263A1 Preli - a novel t-cell regulator |
| 07/31/2008 | WO2008090229A1 Detecting analytes using both an optical and an electrical measurement method |
| 07/31/2008 | WO2008090215A1 Factor vii polypeptides with increased affinity to platelets |
| 07/31/2008 | WO2008090213A1 Methods to diagnose an autoimmune disease and to identify and isolate stimulatory molecules |
| 07/31/2008 | WO2008090186A1 Optical sensor for measuring salinity and visibility in sea water |
| 07/31/2008 | WO2008090177A2 Diagnosis of prostate cancer |
| 07/31/2008 | WO2008089994A1 Use of igfbp-7 in the assessment of heart failure |
| 07/31/2008 | WO2008089961A1 Use of phosphatase inhibitors for the treatment of neurodegenerative diseases |
| 07/31/2008 | WO2008089832A1 Method for risk prediction of a postoperative sepsis in a human |
| 07/31/2008 | WO2008089831A2 G-protein coupled receptor 83 as a molecular switch for the induction of regulatory (immunosuppressive) t-cells |
| 07/31/2008 | WO2008089795A1 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 07/31/2008 | WO2008089767A1 Stacking of optic sensor and microfluidic-chips with optically communication through windows |
| 07/31/2008 | WO2008089764A1 Sensor for an analysis system |
| 07/31/2008 | WO2008089666A1 A high-throughput detect technique for protein or nucleic acid――multi-forms of suspended micro-granular bioreactor |
| 07/31/2008 | WO2008089649A1 Noninvasive method to estimate variation of blood glucose levels using metabolic measurements |
| 07/31/2008 | WO2008089604A1 A device for measuring liquid coagulation time |
| 07/31/2008 | WO2008089577A1 Breast cancer gene array |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089520A1 Method of diagnosis |
| 07/31/2008 | WO2008073424A3 Ansamycin formulations and methods of use thereof |
| 07/31/2008 | WO2008072244B1 Method for antenatal estimation of risk of aneuploidy |
| 07/31/2008 | WO2008071816A3 Integrated system, method and disk for storing data for the chemical analysis of samples and for the detection and storage of the analytical results |
| 07/31/2008 | WO2008069992A3 Method and kit for intracellular delivery |
| 07/31/2008 | WO2008065415A3 Protein precipitation using a tag |
| 07/31/2008 | WO2008064336A9 Autoimmune disease biomarkers |
| 07/31/2008 | WO2008063378A9 Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| 07/31/2008 | WO2008060790A3 Detection of ckd or cad using bmp-4 |
| 07/31/2008 | WO2008057781A3 Portable apparatus for improved sample analysis |
| 07/31/2008 | WO2008054597A9 Tyrosine phosphorylation sites |
| 07/31/2008 | WO2008054394A9 Method and apparatus for detection of toxic agents using photosynthetic organisms |
| 07/31/2008 | WO2008051501A3 Bedbug detection, monitoring and control techniques |
| 07/31/2008 | WO2008051447A3 Human salty taste receptor and methods of modulating salty taste perception |
| 07/31/2008 | WO2008049036A3 Enzyme detection system with caged substrates |
| 07/31/2008 | WO2008045307A3 Emissive compositions with internal standard and related techniques |
| 07/31/2008 | WO2008043768A3 Cellular screening assay for modulation of the g12 and/or g13 pathway |
| 07/31/2008 | WO2008043524A8 Autoantigens for improved diagnosis, prognosis and treatment of inflammatory neurological diseases |
| 07/31/2008 | WO2008038297A3 An apparatus and method for determining the percentage of carbon equivalent, carbon and silicon in liquid ferrous metal |
| 07/31/2008 | WO2008036236A3 Fetuin-a as a biomarker for multiple sclerosis |
| 07/31/2008 | WO2008023268A3 Leukemia mouse model conditionally expressing a bcr-abl oncogene |
| 07/31/2008 | WO2008013558A3 Polypeptide films and methods |
| 07/31/2008 | WO2008009004A9 Reagents for the detection of protein phosphorylation in signaling pathways |
| 07/31/2008 | WO2008008092A3 Campylobacter pilus protein, compositions and methods |
| 07/31/2008 | WO2008005942A3 Activatable probes and methods of use |
| 07/31/2008 | WO2007118200A3 Magnetic drive assembly for petroleum and lpg meter |
| 07/31/2008 | WO2007100640A3 Growth hormone receptor antagonist cancer treatment |
| 07/31/2008 | US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein |
| 07/31/2008 | US20080184379 screening inductive promoting substances of anti-viral proteins such as interferon-beta against lipopolysaccharide stimulation or viral infection by using TBK1 knockout mice, or the tissues or cells derived therefrom |
| 07/31/2008 | US20080183455 Computational method and apparatus for predicting polypeptide aggregation or solubility |
| 07/31/2008 | US20080183399 System and methods for processing analyte sensor data |
| 07/31/2008 | US20080183396 Systems and methods for transmitting pathogen related information and responding |
| 07/31/2008 | US20080183395 Using RNA expression patterns as diagnostic tool in detection of infection and inflammatory disorders; predicting an increased risk to an adverse effect from anti-TNF therapy |
| 07/31/2008 | US20080183394 Polymorphisms in mitochondrial transcription factor A ("TFAM") gene and their associations with carcass traits |
| 07/31/2008 | US20080183062 Method of Distinguishing Among Type a and Type B Acute Aortic Dissection and Acute Myocardial Infraction and Kit For Distinguishment |
| 07/31/2008 | US20080183061 System and methods for processing analyte sensor data |
| 07/31/2008 | US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia |
| 07/31/2008 | US20080182867 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/31/2008 | US20080182811 Activating a metabotropic glutamate receptor by administering one or more kinds of amino acids selected from amino acids other than glutamic acid; use in treating neurological diseases, cardiovascular diseases, surgical diseases, neurosurgical diseases, thoracic surgical diseases, orthopedic diseases |
| 07/31/2008 | US20080182799 Botulinum toxin screening assays |
| 07/31/2008 | US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182784 Reduction or mutation in kalirin indicates senile dementia related to diabetes; Alzheimer's disease; inhibiting nitric oxide cytotoxicity |
| 07/31/2008 | US20080182779 Apelin and uses thereof |
| 07/31/2008 | US20080182778 Identification of an Evolutionarily Conserved Pathway Mediating Transrepression of Inflammatory Response Genes by Nuclear Receptors |
| 07/31/2008 | US20080182775 Administering analogs of luteinizing hormone-releasing hormone, leuprolide; inhibits testosterone secretion |
| 07/31/2008 | US20080182341 Adding a capture ligand for the free analyte and a stabilizing agent, an analyte and a detection system; measuring the concentration of the analyte in the sample |
| 07/31/2008 | US20080182339 Methods for allergen detection |
| 07/31/2008 | US20080182334 Method and Kit For Detecting Explosive Substances Containing Certain Oxidants |
| 07/31/2008 | US20080182333 Metal binding, electron donating dipyrrin functionality linked to electron withdrawing functionality, base to which chemosensor can be fixedly attached; for quantitative and qualitative sensing of +2 transition metals using ratiometric fluorescence capable of forming stable transition metal complex |
| 07/31/2008 | US20080182329 Methods and products related to metabolic interactions in disease |
| 07/31/2008 | US20080182324 using an enzyme-coenzyme complex as stoichiometric reactant instead of, as usual, as catalyst; Detection of the analyte requires only a single reaction step and is therefore extremely fast |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182316 Nucleic acids encoding opiate receptors |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182300 Kit comprising RNA/DNA hybrid primer, template switch oligonucleotides (TSO) and cyclical replication of RNA sequences |
| 07/31/2008 | US20080182299 Polynucleotide variants of brain natriuretic peptides used as diagnostic markers for cardiovascular diseases including myocardial infarct, acute coronary syndrome, angina pectoris (stable and unstable), cardiomyopathy, myocarditis, congestive heart failure; kits; monitoring disease progression , relapse |
| 07/31/2008 | US20080182293 Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080182287 Gel Formulations and Uses Thereof |
| 07/31/2008 | US20080182284 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
| 07/31/2008 | US20080182282 Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same |
| 07/31/2008 | US20080182281 detection sensitivity comparable to that in a conventional determination method, easy to handle a sample after collection, and highly reproducible measurements; diagnoses, monitoring of the treatment, monitoring of recurrence, or the like of various diseases including small cell lung cancer |
| 07/31/2008 | US20080182280 Using anti-neutrophil cytoplasmic antibody (ANCA) as diagnostic indicator of gastrointestinal disorders; differentiating between Crohn's disease, ulcerative colitis, and indeterminate colitis; monitoring the efficacy of IBD therapy, monitoring the progression or regression of IBD |